1. Proteomic Analysis Reveals That Metformin Suppresses PSMD2, STIP1, and CAP1 for Preventing Gastric Cancer AGS Cell Proliferation and Migration
   Wei-Hsuan Wang et al, 2021, ACS Omega CrossRef
2. Chemopreventive Effect of Metformin on Gastric Cancer Development
   Ka Shing Cheung et al, 2022, Gut and Liver CrossRef
3. Effects of metabolic cancer therapy on tumor microenvironment
   Petra Hyroššová et al, 2022, Frontiers in Oncology CrossRef
4. The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors
   Samaneh Mostafavi et al, 2022, Cellular & Molecular Biology Letters CrossRef
5. Drug Repurposing in Gastric Cancer: Current Status and Future Perspectives
   Marina Leite et al, 2023, Hereditary Gastric and Breast Cancer Syndrome CrossRef
6. The therapeutic potential of metformin in gastric cancer
   Sarah Courtois et al, 2019, Gastric Cancer CrossRef
7. Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism
   Christoph Metzendorf et al, 2020, Molecules CrossRef
8. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature
   Chin-Hsiao Tseng, 2021, Biomolecules CrossRef
9. Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer
   Yuanda Liu et al, 2022, Frontiers in Immunology CrossRef
10. Transplantation of the Stromal Vascular Fraction (SVF) Mitigates Severe Radiation-Induced Skin Injury
    Daojiang Yu et al, 2021, Radiation Research CrossRef
11. Research Progress on Anti-Tumor Effect of Metformin in Gastric Cancer
    礼琴 贺, 2019, Advances in Clinical Medicine CrossRef
12. Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
    Mario Cioce et al, 2020, Cells CrossRef